Wai Chun Bio-Technology Ltd. (HK:0660) has released an update.
Wai Chun Bio-Technology Limited has appointed Mr. Fenn David as their new authorised representative, effective from September 16, 2024, ensuring compliance with the Hong Kong Stock Exchange’s requirement for two authorised representatives. This follows the recent resignation of the previous authorised representative, Mr. Lam Kai Kei. The company’s leadership includes an executive director and three independent non-executive directors.
For further insights into HK:0660 stock, check out TipRanks’ Stock Analysis page.
